News - Filgrastim

Filter

Current filters:

Filgrastim

Popular Filters

EGA Biosimilars: Prescribers must be encouraged to use biosimilars

EGA Biosimilars: Prescribers must be encouraged to use biosimilars

07-04-2014

Uptake of biosimilars in Europe has increased as a result of member states’ policies, according to…

BiosimilarsEuropeFilgrastimInterviewsMarkets & MarketingRegulationSandoz

UK lags behind some European countries in biosimilars uptake, new study finds

12-09-2013

New research has shown that the UK lags behind some European countries in terms of biosimilars uptake,…

CellTrionepoetinEuropeFilgrastimGenericsHealthcareinfliximabJohnson & JohnsonRemsima

Uptake for biosimilars in the UK lags behind other EU markets

17-07-2013

The UK lags behind some European countries in biosimilars with just 30% volume uptake despite the high…

EuropeFilgrastimGenericsHealthcareSomatropin

Sandoz initiates two more Phase III biosimilar trials

20-01-2012

Sandoz, the generics unit of Swiss drug major Novartis (NOVN: VX), says that it has initiated two milestone…

AmgenBiotechnologyFilgrastimGenericsNovartisOncologypegfilgrastimResearchSandozZarzio

Back to top